Publication|Videos|February 13, 2025
Implementing Diversity, Equity, and Inclusion in Drug Development
Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center for the Study of Drug Development, discusses barriers to participation for underrepresented populations in clinical trials and how Tufts is conducting research to better understand their nature.
Advertisement
Episodes in this series
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
2
Engineered Bispecific Antibodies: Regulatory, Ethical, and Best Practice Guidelines
3
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
4
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
